Federal contract award
75N93021C00009
GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.6M |
| Current contract value | $6.6M |
| Potential contract value / ceiling | $6.6M |
| Start date | Mar 16, 2021 |
| Current end date | Feb 28, 2025 |
| Potential end date | Feb 28, 2025 |
| Latest award activity | Aug 20, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 20, 2026 | P00011 | $-1.8K | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Oct 30, 2024 | P00010 | $0 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Sep 20, 2024 | P00009 | $138.0K | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Dec 22, 2023 | P00008 | $0 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Sep 12, 2023 | P00007 | $500.0K | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Mar 8, 2023 | P00006 | $1.6M | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Sep 16, 2022 | P00004 | $1.0M | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Sep 16, 2022 | P00005 | $0 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Mar 4, 2022 | P00003 | $1.7M | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Oct 15, 2021 | P00002 | $0 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Jun 8, 2021 | P00001 | $0 | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
| Mar 15, 2021 | 0 | $1.7M | GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Apr 8, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Apr 8, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Apr 1, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Apr 1, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Mar 26, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Mar 26, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Mar 20, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Mar 20, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Mar 13, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Mar 13, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Mar 6, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Mar 6, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Feb 27, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Feb 27, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Feb 24, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Feb 24, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Feb 13, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Feb 13, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Feb 4, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Feb 4, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Jan 21, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Jan 21, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Jan 3, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Jan 3, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Jan 3, 2020 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Jan 3, 2020 |
| Swee L. Teo | Contact | teosl@niaid.nih.gov 240-669-5173 | Source | Dec 11, 2019 |
| Brian Madgey | Contact | brian.madgey@nih.gov 240-627-3712 | Source | Dec 11, 2019 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.